Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis

OBJECTIVES: To investigate whether patients with rheumatoid arthritis (RA) can discontinue glucocorticoids (GC) after GC ‘bridging’ in the initial treatment step and to identify factors that may affect this. METHODS: Data from 7 clinical trial arms (with 1653 patients) that included a GC bridging sc...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ouwerkerk, Lotte, Boers, Maarten, Emery, Paul, de Jong, Pascal HP, Landewé, Robert BM, Lems, Willem, Smolen, Josef S, Verschueren, Patrick, Huizinga, Tom WJ, Allaart, Cornelia F, Bergstra, Sytske Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086274/
https://www.ncbi.nlm.nih.gov/pubmed/36526336
http://dx.doi.org/10.1136/ard-2022-223443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086274/
https://www.ncbi.nlm.nih.gov/pubmed/36526336
http://dx.doi.org/10.1136/ard-2022-223443

Ejemplares similares